<?xml version="1.0" encoding="UTF-8"?>
<p>
 <italic>Reviews</italic>: Wee LE, Chan YFZ, Teo NWY, Cherng BPZ, Thien SY, Wong HM et al. Eur Arch Otorhinolaryngol. 2020 doi: 
 <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/s00405-020-05999-5" xmlns:xlink="http://www.w3.org/1999/xlink">10.1007/s00405-020-05999-5</ext-link> (online April 24). This article supports the use of self-surveys for evaluation of olfactory disorders, in Covid 19; Xydakis MS, Dehgani-Mobaraki P, Holbrook EH, Geisthoff UW, Bauer C, Hautefort C Lancet Infect Dis. 2020 doi: 
 <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/S1473-3099(20)30293-0" xmlns:xlink="http://www.w3.org/1999/xlink">10.1016/S1473-3099(20)30293-0</ext-link> (online April 15). It is an editorial comment in line with our article in which it is noted that is noteworthy that the olfactory alterations of Covid 19 do not correlated with alterations such as rhinorrhea similar to our considerations.; Lovato A, by Filippis C. Ear Nose Throat J. 2020. doi: 
 <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1177/0145561320920762" xmlns:xlink="http://www.w3.org/1999/xlink">10.1177/0145561320920762</ext-link> (online April 13). It is a meta-analysis of 5 studies. Interesting, phharyngodynia was only present in 12.4% of patients, nasal congestion in 3.7%, and rhinorrhea was rare;. Dufowt R and Rusell K (online April 13), ACS Chem Neurosci, doi: 
 <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1021/ascchemneuro.0c00172" xmlns:xlink="http://www.w3.org/1999/xlink">10.1021/ascchemneuro.0c00172</ext-link>.
</p>
